Clarithromycin Tablet, Film Coated
Product Images NDC 46708-344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 46708-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clarithromycin-250-mg-apl.jpg (Clarithromycin 250 mg Apl)

Clarithromycin-250-mg-apl.jpg (Clarithromycin 250 mg Apl)
Clarithromycin Tablets, USP 250 mg film-coated oral tablets label from Alembic Pharmaceuticals Limited. The label includes the NDC 46708-344-30, directions for storage at controlled room temperature, and packaging details for a bottle containing 30 tablets.*
FDA Label Image

Clarithromycin-500-mg-apl.jpg (Clarithromycin 500 mg Apl)

Clarithromycin-500-mg-apl.jpg (Clarithromycin 500 mg Apl)
Label for Clarithromycin Tablets USP, 500 mg film-coated tablets, oral use. The label states the product contains 500 mg clarithromycin per tablet and includes manufacturer information for Alembic Pharmaceuticals Limited in Gujarat, India. Packaging is for 30 tablets with storage instructions, a barcode, and caution about seal integrity.*
FDA Label Image

Figure 2 (Clarithromycin Figure2)

Figure 2 (Clarithromycin Figure2)
A line graph illustrating mean plasma concentration (mcg/mL) over time (hours) after dosing for Clarithromycin. It compares Clarithromycin extended-release tablets (2 x 500 mg every 24 hours) and standard Clarithromycin tablets (500 mg every 12 hours), showing concentration changes up to 24 hours post-dose.*
FDA Label Image

Figure 3 (Clarithromycin Figure3)

Figure 3 (Clarithromycin Figure3)
A survival curve chart comparing the proportion surviving over time between two groups: Clarithromycin and Placebo. The x-axis shows days since randomization, ranging from 0 to approximately 700, while the y-axis represents the proportion surviving from 0 to 1. Clarithromycin is represented by a solid line, placebo by a dotted line.*
FDA Label Image

Structure (Clarithromycin Structure)

Structure (Clarithromycin Structure)
Chemical structure of clarithromycin, showing its molecular configuration with labeled atoms and chemical bonds as depicted in the schematic diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.